Key features and details
- Rabbit polyclonal to NIPA (phospho S354)
- Suitable for: ELISA, WB
- Reacts with: Human
- Isotype: IgG
Product nameAnti-NIPA (phospho S354) antibody
See all NIPA primary antibodies
DescriptionRabbit polyclonal to NIPA (phospho S354)
SpecificityDetects NIPA only when phosphorylated at serine 354.
Tested applicationsSuitable for: ELISA, WBmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat
Synthetic phosphopeptide derived from human NIPA around the phosphorylation site of serine 354 (T-R-SP-W-D).
Storage instructionsShipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
Storage bufferpH: 7.40
Preservative: 0.02% Sodium azide
Constituents: PBS, 50% Glycerol, 0.87% Sodium chloride
Without Mg2+ and Ca2+
Concentration information loading...
PurityImmunogen affinity purified
Purification notesPurified from rabbit antiserum by affinity chromatography using epitope specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Our Abpromise guarantee covers the use of ab63557 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/500 - 1/1000. Detects a band of approximately 55 kDa (predicted molecular weight: 55 kDa).|
FunctionEssential component of an SCF-type E3 ligase complex, SCF(NIPA), a complex that controls mitotic entry by mediating ubiquitination and subsequent degradation of cyclin B1 (CCNB1). Its cell-cycle-dependent phosphorylation regulates the assembly of the SCF(NIPA) complex, restricting CCNB1 ubiquitination activity to interphase. Its inactivation results in nuclear accumulation of CCNB1 in interphase and premature mitotic entry. May have an antiapoptotic role in NPM-ALK-mediated signaling events.
Tissue specificityWidely expressed. Highly expressed in heart, skeletal muscle and testis. Expressed in brain, placenta, lung, kidney, liver, pancreas, spleen, thymus, prostate, ovary small intestine and colon. Weakly or not expressed in leukocytes.
PathwayProtein modification; protein ubiquitination.
Sequence similaritiesContains 1 C3HC-type zinc finger.
Developmental stageWeakly expressed in G0/G1 phases, abundant during S and G2/M phases, and strongly decreases thereafter.
DomainThe F-box-like region is required for the interaction with SKP1.
modificationsPhosphorylated. Phosphorylated on Ser residues at G2/M phase, but not during S and G0 phases. May also be weakly phosphorylated on Tyr residues. Ser-354 phosphorylation, a major site during the course of cell-cycle-dedendent phosphorylation, results in its dissociation from the SCF(NIPA) complex, thereby preventing CCNB1 degradation leading to mitotic entry.
- Information by UniProt
- hNIPA antibody
- NIPA_HUMAN antibody
- Nuclear interacting partner of ALK antibody
All lanes : Anti-NIPA (phospho S354) antibody (ab63557) at 1/500 dilution
Lane 1 : extracts from COS7 cells, treated
with HU (2nM, 24hours)
Lane 2 : extracts from COS7 cells, treated
with HU (2nM, 24hours) with immunizing phosphopeptide at 10 µg
Lysates/proteins at 30 µg per lane.
Predicted band size: 55 kDa
Observed band size: 55 kDa
Additional bands at: 30 kDa, 75 kDa. We are unsure as to the identity of these extra bands.
ab63557 has been referenced in 2 publications.
- Zhao M et al. Methylene blue exerts a neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation. Mol Med Rep 13:13-20 (2016). WB ; Mouse . PubMed: 26572258
- Illert AL et al. Extracellular signal-regulated kinase 2 (ERK2) mediates phosphorylation and inactivation of nuclear interaction partner of anaplastic lymphoma kinase (NIPA) at G2/M. J Biol Chem 287:37997-8005 (2012). WB . PubMed: 22955283